Xuan Xu Selected Research

Xuan Xu Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 11/2009
9	Inflammation (Inflammations) 02/2024 - 06/2008
7	Infections 11/2020 - 04/2010
6	Heart Failure 01/2024 - 11/2009
6	COVID-19 03/2023 - 11/2020
6	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 10/2019
5	Hypertrophy 01/2023 - 01/2017
4	Ischemia 03/2024 - 05/2009
4	Cardiomegaly (Heart Hypertrophy) 11/2023 - 10/2019
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 06/2020
4	Hypertension (High Blood Pressure) 01/2023 - 01/2021
4	Hemorrhage 01/2023 - 11/2009
4	Pulmonary Hypertension 12/2018 - 01/2015
3	Fibrosis (Cirrhosis) 12/2024 - 08/2009
3	Obesity 03/2024 - 01/2023
3	Drug-Related Side Effects and Adverse Reactions 03/2023 - 01/2021
3	Stroke (Strokes) 01/2023 - 11/2013
3	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 03/2011
3	Carcinogenesis 12/2021 - 05/2006
3	Congenital tracheal stenosis 01/2020 - 05/2012
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2015
3	Reperfusion Injury 01/2015 - 05/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 05/2009
2	Hyperalgesia 11/2023 - 01/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2023 - 01/2023
2	Non-alcoholic Fatty Liver Disease 01/2023 - 12/2018
2	Diabetes Mellitus 01/2023 - 11/2022
2	Ischemic Stroke 01/2023 - 01/2023
2	Pancreatitis 01/2023 - 03/2022
2	Hypoxia (Hypoxemia) 01/2022 - 06/2013
2	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2015
2	Infarction (Infarctions) 01/2021 - 09/2009
2	Neoplasm Metastasis (Metastasis) 12/2020 - 11/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2020 - 01/2017
2	Pathologic Processes 03/2020 - 12/2013
2	Enteritis 02/2020 - 01/2018
2	Dyspnea (Shortness of Breath) 01/2020 - 05/2014
2	Hyperplasia 01/2020 - 05/2014
2	Pathologic Constriction (Stenosis) 01/2020 - 11/2013
2	Airway Obstruction (Choking) 05/2014 - 05/2012
2	Pulmonary Atelectasis 05/2014 - 11/2013
2	Sepsis (Septicemia) 11/2013 - 05/2012
1	Acute Kidney Injury (Acute Renal Failure) 03/2024
1	Ulcerative Colitis 03/2024
1	Vascular System Injuries 02/2024
1	Bradycardia 02/2024
1	Decompression Sickness (Bends) 12/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2006
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
5	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2015
4	RNA (Ribonucleic Acid)IBA 12/2023 - 09/2021
4	CytokinesIBA 11/2023 - 01/2015
4	Long Noncoding RNAIBA 12/2021 - 10/2019
3	CollagenIBA 11/2023 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2017
3	Messenger RNA (mRNA)IBA 10/2017 - 06/2008
2	Neuroprotective AgentsIBA 05/2023 - 11/2022
2	Heparin (Liquaemin)FDA LinkGeneric 03/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2021
2	LipidsIBA 01/2023 - 11/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2022 - 12/2020
2	Mitogen-Activated Protein KinasesIBA 12/2022 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 12/2021
2	hepatitis B virus X proteinIBA 11/2022 - 12/2021
2	Nucleic AcidsIBA 11/2022 - 05/2020
2	Indicators and Reagents (Reagents)IBA 11/2022 - 04/2010
2	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
2	HomocysteineIBA 01/2022 - 11/2013
2	Angiotensin IIIBA 01/2022 - 10/2019
2	Co-Repressor ProteinsIBA 12/2021 - 08/2008
2	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 06/2020
2	Hormones (Hormone)IBA 04/2021 - 11/2009
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 11/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 11/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 11/2020
2	Plant ProteinsIBA 02/2020 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2018 - 11/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 01/2015
1	Insulin-Like PeptidesIBA 12/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2024
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2024
1	Circular RNAIBA 03/2024
1	vedolizumabIBA 03/2024
1	upadacitinibIBA 03/2024
1	Infliximab (Remicade)FDA Link 03/2024
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024
1	Fingolimod Hydrochloride (FTY720)FDA Link 02/2024
1	shexiang baoxinIBA 01/2024

Therapy/Procedure

11	Therapeutics 02/2024 - 11/2009
6	Stents 01/2023 - 05/2012
3	Length of Stay 03/2022 - 11/2017
3	Artificial Respiration (Mechanical Ventilation) 03/2018 - 11/2013
2	Aftercare (After-Treatment) 01/2023 - 10/2021
2	Central Venous Catheters 03/2018 - 11/2017
2	Parenteral Nutrition 03/2018 - 11/2017
2	Extracorporeal Membrane Oxygenation 06/2013 - 11/2009
1	Intravenous Injections 12/2024
1	Biological Therapy 03/2024